* VBL Therapeutics announces second quarter 2016 financial
results and provides business update
The post BRIEF-VBL Therapeutics posts Q2 loss per share of $0.14 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* VBL Therapeutics announces second quarter 2016 financial
results and provides business update
The post BRIEF-VBL Therapeutics posts Q2 loss per share of $0.14 appeared first on NASDAQ.